explore -WSS

explore

author：explore 2025-09-29 09:29:43 - browse：942

LONDON — Seeking to build up its pharma business, the Japanese conglomerate Asahi Kasei is moving to buy Swedish biotech Calliditas Therapeutics in a nearly $1.1 billion cash deal, the companies said Tuesday.

The firm’s offer of $19.68 per share amounts to an 83% premium versus Calliditas’ closing price on a Swedish exchange Monday. The Calliditas board has unanimously recommended that shareholders accept the offer, the company said, adding that it “aims to realize the benefits of being part of a larger platform” by being acquired.

Calliditas has an approved drug on the U.S. market called Tarpeyo, which treats a kidney disease called IgA nephropathy. The condition has in recent years attracted interest from a number of pharma companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Grail is spending more than ever lobbying Congress

WSS

A new study asks: Are we harming blood donors by taking blood?

Meta looks to target Twitter with a rival app called Threads

Nonprofit, backed by Microsoft, to certify AI tools in health care

Bacterial infection may be ‘key event’ in endometriosis, study says

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Physician assistants need a new name. Here's what it should be

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

PhRMA sues HHS over Medicare drug price negotiation

United colonoscopy coverage change 'may cost lives,' doctors say

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Heart attack and stroke risk calculators need revising

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

New air purifier tech could be key to improving indoor air quality

4th of July breaks record for highest global temperature ever measured

George Santos makes 1st court appearance after pleading not guilty to 13 counts

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

focus

A new study asks: Are we harming blood donors by taking blood?

Boston Scientific acquires urology company Axonics for $3.7 billion

In shift, Texas to cover initial consult for Afghan baby's gene therapy

4th of July breaks record for highest global temperature ever measured

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

FDA early review: GLP

hotspot

Wikipedia

knowledge

entertainment